Live
- Celta Vigo extend all-time club top-scorer Iago Aspas’ contract till 2026
- BGT: Kaif gives preference to Jaiswal-Rahul opening pair for Boxing Day Test against Australia
- Odisha CM Majhi, Naveen Patnaik extend Christmas greetings
- Icebreaker Keyboard: AluminIum Design Costing as Much as a MacBook Pro
- ‘Rifle Club’ Movie Review: A Stylish Thriller That Falls Short in Storytelling
- Chennai to Experience Heavy Rain as Severe Low-Pressure System Approaches Coastal Areas
- Pradeep’s ‘Akkada Ammayi Ikkada Abbayi’ hypes up with energetic new song
- Dil Raju releases ‘Adi Dha Saaru’ song from ‘Sahakutumbanam’
- GTA 5 Online Car Duplication Glitch: How to Duplicate Cars for Money (2024)
- 'Srikakulam Sherlock Holmes' Review: A quirky thriller thay doesn’t impress
Roche brings cancer drug to India
Drug firm Roche India on Thursday said it has launched Atezolizumab used for the treatment of small cell lung cancer in India after getting nod from Drugs Controller General of India.
New Delhi: Drug firm Roche India on Thursday said it has launched Atezolizumab used for the treatment of small cell lung cancer in India after getting nod from Drugs Controller General of India.
"Atezolizumab is the first cancer immunotherapy to receive an approval in India for the first line treatment of extensive-stage small cell lung cancer (ES-SCLC) when given in combination with chemotherapy," Roche India said in a statement.
The cancer immunotherapy harnesses the person's immune system to combat cancer more effectively for better results, it added.
"Roche is committed to bring to India all the innovations being developed in its pipeline, to benefit patients," Lara Bezerra, chief purpose officer at Roche Products (India) said.
Launching Atezolizumab is an important step for small cell lung cancer patients in India, she added.
